$18.70
-0.14 (-0.74%)
Open$18.97
Previous Close$18.84
Day High$19.18
Day Low$18.51
52W High$21.27
52W Low$4.05
Volume—
Avg Volume3.34M
Market Cap4.21B
P/E Ratio—
EPS$-1.57
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+248.8% upside
Current
$18.70
$18.70
Target
$65.23
$65.23
$47.67
$65.23 avg
$99.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.56M | 8.30M | 220.69M |
| Net Income | -352,185,291 | -252,156,044 | 45.13M |
| Profit Margin | -1,800.6% | -3,206.0% | 20.5% |
| EBITDA | -381,102,385 | -289,236,526 | 96.01M |
| Free Cash Flow | — | — | 41.24M |
| Rev Growth | +123.3% | +48.9% | +11.7% |
| Debt/Equity | — | — | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |